Drug Profile
Vonapanitase - Protara Therapeutics
Alternative Names: PRT 201; Recombinant-human-type-I-pancreatic-elastaseLatest Information Update: 21 Mar 2022
Price :
$50
*
At a glance
- Originator Proteon Therapeutics
- Developer Protara Therapeutics; Proteon Therapeutics
- Class Elastases; Recombinant proteins; Vascular disorder therapies
- Mechanism of Action Extracellular matrix protein modulators; Pancreatic elastase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Peripheral arterial disorders; Vascular disorders